<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Extended-release opioid preparations for chronic pain</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Extended-release opioid preparations for chronic pain</h1>
<div class="graphic"><div class="figure"><div class="ttl">Extended-release opioid preparations for chronic pain</div><div class="cntnt"><table cellspacing="0"><colgroup span="3" width="33.3%"></colgroup> <tbody> <tr> <td class="subtitle1">Opioid preparation<br/> (US brand name)</td> <td class="subtitle1">Available preparations</td> <td class="subtitle1">Usual dosing interval</td> </tr> <tr> <td>Buprenorphine transdermal patch (Butrans)</td> <td>5, 7.5, 10, 15, 20 mcg/hour transdermal patches</td> <td>Seven days</td> </tr> <tr> <td>Buprenorphine buccal film (Belbuca)*</td> <td>75, 150, 300, 450, 600, 750, 900 mcg buccal films</td> <td>12 or 24 hours</td> </tr> <tr> <td>Fentanyl transdermal patch (Duragesic)</td> <td>12, 25, 50, 75, 87.5, 100 mcg/hour</td> <td>Three days</td> </tr> <tr> <td>Hydrocodone ER 12 hour (Zohydro ER)</td> <td>10, 15, 20, 30, 40, 50 mg capsules</td> <td>12 hours</td> </tr> <tr> <td>Hydrocodone ER 24 hour (Hysingla ER)</td> <td>20, 30, 40, 60, 80, 100, 120 mg tablets</td> <td>24 hours</td> </tr> <tr> <td>Hydromorphone ER 24 hour (Exalgo)</td> <td>8, 12, 16, 32 mg tablets</td> <td>24 hours</td> </tr> <tr> <td>Methadone<sup>¶</sup></td> <td>5, 10 mg tablets</td> <td>8 to 12 hours</td> </tr> <tr> <td>Morphine sulfate ER 24 hour (Kadian)</td> <td>10, 20, 30, 45, 50, 60, 75, 80, 90, 120, 200 mg capsules</td> <td>24 hours</td> </tr> <tr> <td>Morphine sulfate ER (MS Contin)</td> <td>15, 30, 60, 100, 200 mg tablets</td> <td>8 to 12 hours</td> </tr> <tr> <td>Oxycodone ER 12 hour<sup>Δ</sup> (OxyContin)</td> <td>10, 15, 20, 30, 40, 60, 80 mg tablets</td> <td>12 hours</td> </tr> <tr> <td>Oxycodone ER 12 hour<sup>Δ</sup> (Xtampza ER)</td> <td>9, 13.5, 18, 27, 36 mg capsules</td> <td>12 hours</td> </tr> <tr> <td>Oxymorphone ER 12 hour (Generic only)</td> <td>5, 7.5, 10, 15, 20, 30, 40 mg tablets</td> <td>12 hours</td> </tr> <tr> <td>Tapentadol ER<sup>◊</sup> (Nucynta ER)</td> <td>50, 100, 150, 200, 250 mg tablets</td> <td>12 hours</td> </tr> <tr> <td>Tramadol ER 24 hour (Ultram ER)</td> <td>100, 150, 200, 300 mg tablets and capsules</td> <td>24 hours</td> </tr> </tbody></table></div><div class="graphic_lgnd"><ul>
<li>Refer to UpToDate for information on the role of opioids in the treatment of chronic pain.</li>
<li>The total daily dose requirement for use of a long-acting formulation should be established first with the use of an appropriate immediate-release opioid analgesic.</li>
<li>Brand (trade) names and strengths listed in the table are for products available in the US and some other countries.</li></ul></div><div class="graphic_footnotes">US: United States; ER: extended-release; MS: morphine sulphate.<br/>* Although buprenorphine buccal film is not an extended release preparation, it can be used as a long-acting opioid due to its prolonged half-life of approximately 28 hours.<br/>¶ Due to challenges inherent in safe prescribing of methadone, it is not typically a first-line analgesic choice. Although methadone is not an ER preparation, it can be used as a long-acting opioid due to its prolonged half-life (0.5 to 7 days); guidelines for safe administration must be followed to reduce risk of unintentional overdose. Refer to UpToDate topic on cancer pain management with opioids, section on methadone.<br/>Δ Dose of ER tablets is expressed as oxycodone hydrochloride and the dose of ER capsules is expressed as oxycodone base; 10 mg of oxycodone hydrochloride is equivalent to 9 mg oxycodone base.<br/>◊ Patients should not consume alcoholic beverages or use prescription or nonprescription products that contain alcohol while taking tapentadol ER. The combination of alcohol with tapentadol ER may result in increased plasma tapentadol levels and a potentially fatal overdose of tapentadol.</div><div class="graphic_reference">Data from: Lexicomp Online. Copyright © 1978-2024 Lexicomp, Inc. All Rights Reserved.</div><div id="graphicVersion">Graphic 108954 Version 18.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
